Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
clinical trial design
Biotech
Lilly oncology head weighs in on FDA cancer drug policies
Lilly’s oncology chief, Jake Van Naarden, suggested that the FDA's policies on clinical trial crossover and high U.S. enrollment are not compatible.
Angus Liu
Oct 21, 2025 11:53am
PhaseV launches trial optimization software into CRO's services
Sep 10, 2025 12:54pm
FDA considers new liver trial endpoint, sending MASH shares up
Aug 28, 2025 11:25am
Flagship taps IQVIA as biotech support for company fleet
Aug 28, 2025 11:13am
FDA draft recommends all cancer trials collect OS data
Aug 20, 2025 10:59am
Bayer boosts precision oncology efforts with multiyear AI deal
Apr 23, 2025 12:55pm
